This guide sets out what the SmPC recognises about Mounjaro and the skin, what 'Ozempic face' actually is, and when a skin reaction needs attention. It draws on the UK Summary of Product Characteristics and the NHS, and it is careful to separate drug effects from the effects of weight loss.
Mounjaro and the skin: what is recognised
The skin-related effects the SmPC actually lists are injection site reactions and hypersensitivity reactions, alongside hair loss, which we touch on later 1. The NHS lists itchy or red skin where you inject among the common side effects, and notes that redness may be harder to see on brown or black skin 3.
What is not a listed drug effect is the facial change people call 'Ozempic face' or 'Mounjaro face'. That is a consequence of losing weight, not a direct action of the medicine on the skin, and we cover it separately below 3. Keeping that distinction clear is the key to this topic.
So the recognised skin effects are mostly about the injection site and occasional hypersensitivity, both covered next, while facial changes belong to the weight-loss side of the picture 13.
This distinction is the most useful thing to take from the whole topic. When you read about Mounjaro and skin online, a lot of it blends genuine drug effects (injection site reactions, occasional rash) with effects of weight loss (facial hollowing) and even unrelated skin conditions 13. Keeping them separate, drug effects from the SmPC, weight-loss effects from the result you are seeking, tells you what to expect and what, if anything, to act on 1.
Injection site reactions
The most common skin effect is a reaction where you inject. In the pooled weight management trials, injection site reactions were reported in around 8 percent of people on tirzepatide compared with about 2 percent on placebo, and the most common signs were redness and itching 1. They were mild in the large majority of cases and none were serious 1.
Rotating the injection site with each weekly dose helps reduce these, which is why the SmPC and NHS both advise using the same general area but not the exact same spot each time 13. The NHS also notes that redness may be harder to see on brown or black skin, so it is worth feeling for warmth or itching as well as looking 3.
Most injection site reactions settle on their own and are part of the normal experience of a weekly injection 1. Our guide on where to inject Mounjaro safely covers site rotation and technique, which is the main way to minimise them.
A few practical habits reduce them further. Using a fresh spot each week within the approved sites, the abdomen, thigh or upper arm, rather than the exact same point, gives the skin time to recover between injections 1. Letting the site settle and not scratching it helps, and a reaction that is mild redness or itch and fades over a day or two is the expected pattern 1. If a particular area keeps reacting, simply moving to a different approved site usually solves it 1.
Skin sensitivity, rash and allergic reactions
Beyond the injection site, the SmPC lists hypersensitivity reactions, which were reported in around 5 percent of people in the weight management trials versus about 4 percent on placebo, and were sometimes more significant, including urticaria (hives), eczema, dermatitis and rash 1. So a rash or itchy, sensitive skin can occur as a hypersensitivity reaction 1.
The pen also contains a small amount of benzyl alcohol as an excipient, which the SmPC notes can rarely cause allergic reactions 2. Most skin sensitivity is mild, but the important exception is a serious allergic reaction: the NHS lists anaphylaxis, with symptoms such as a swollen throat or tongue, a raised itchy rash or difficulty breathing, among the rare serious side effects 3.
So the spectrum runs from mild, common itchiness or rash, which usually settles, to rare serious allergic reactions, which are an emergency 13. If a rash is widespread, severe, or comes with swelling or breathing difficulty, treat it as urgent 3.
It is also worth noting who should be cautious from the start. The NHS flags that tirzepatide may not be suitable if you have had an allergic reaction to it or to another GLP-1 medicine, so a previous reaction to this class is important to disclose before starting 3. For most people, though, skin reactions are mild and a normal part of settling onto the medicine, and a pharmacist can advise on managing persistent itch or rash 13.
Considering treatment for weight management? You can start an assessment with a Cloud Pharmacy clinician, who will review your medical history and confirm whether treatment is appropriate.
'Ozempic face' and facial changes
The trending term 'Ozempic face' (sometimes 'Mounjaro face') describes a hollowed, more aged look in the face that some people notice during treatment. The important point is that this is a consequence of weight loss, including loss of facial fat, not a listed side effect of the medicine acting on the skin 3. The SmPC does not describe it as a drug effect.
Significant or rapid weight loss from any cause can reduce facial fat and change appearance, so this is really a feature of losing weight rather than something specific to tirzepatide 3. Framing it that way helps set expectations: it reflects the result the medicine is aiming for, not a separate skin problem.
Because it is tied to the pace and amount of weight loss rather than the drug itself, there is no medicine-specific fix for it in the SmPC; it is part of the wider conversation about weight loss, which a prescriber can discuss with you 3. This is also a reason the aim is steady, sustainable weight loss rather than the fastest possible, as our guide on whether rapid weight loss is safe explores.
It also helps to keep the term in perspective. 'Ozempic face' is a media label for something that has always accompanied significant weight loss, the face reflecting the loss of fat that is happening elsewhere in the body 3. It is not evidence that the medicine is harming your skin, and for many people facial change is simply part of the overall result they are seeking 3. If the pace of facial change concerns you, that is a reasonable thing to raise with your prescriber as part of discussing your rate of weight loss 3.
Hair changes
Hair loss is also reported, and it sits alongside the skin questions people raise. In the weight management trials, hair loss was reported in 4.9 percent of people on tirzepatide versus 1 percent on placebo, was mostly mild, and most people recovered while still on treatment 1.
Like facial changes, hair loss is partly linked to weight loss itself, which can be a trigger for temporary shedding, rather than being a direct skin effect of the drug 1. Our guide on Mounjaro side effects covers hair loss alongside the other effects.
The reassuring point from the trial data is that the hair loss was mostly mild and tended to recover during continued treatment 1. Persistent or severe hair loss is worth raising with a clinician, who can check for other causes 3.
When to seek advice
Most skin effects are mild and settle. The NHS advises speaking to a pharmacist or doctor about side effects that bother you or do not go away, which covers persistent injection site reactions, rashes or skin sensitivity 3. Rotating sites and following the pen instructions help with injection site reactions 1.
Some situations are urgent. A serious allergic reaction, with a swollen throat or tongue, a widespread raised itchy rash or difficulty breathing, needs emergency attention, and the NHS advises calling 111 if you think you might be having serious side effects 3. A severe, spreading or blistering rash also warrants prompt medical advice 3.
You can report skin reactions and any suspected side effects through the MHRA Yellow Card scheme, which helps keep the safety picture current for this relatively new medicine 1. For facial changes from weight loss, the conversation is with your prescriber as part of the wider weight-loss picture rather than an urgent medical issue 3.
As a simple rule of thumb, the everyday skin effects, mild injection site redness or itching and the odd patch of sensitivity, are things to manage and mention if they persist, while a fast-spreading or blistering rash, or any rash with swelling of the face, lips or throat or with breathing difficulty, is the kind that should never be left to settle on its own 13. Keeping that distinction in mind takes the worry out of the common reactions while making sure the rare serious one is acted on quickly 3.
Frequently asked questions
Does Mounjaro cause skin sensitivity or rash?
It can. The SmPC lists hypersensitivity reactions, reported in around 5 percent of people in the weight management trials, sometimes including hives, eczema, dermatitis and rash, and injection site reactions such as redness and itching are common 1. The pen's benzyl alcohol can rarely cause allergic reactions 2. Severe or spreading rash, or swelling and breathing difficulty, needs urgent attention 3.Does Mounjaro skin sensitivity go away?
Most skin effects are mild and settle. Injection site reactions are usually mild and helped by rotating the site, and general skin sensitivity often eases 13. If it persists or bothers you, the NHS advises speaking to a pharmacist or doctor rather than stopping the medicine yourself 3. A severe allergic skin reaction is a separate emergency 3.Is 'Ozempic face' a Mounjaro side effect?
Not a listed drug effect. 'Ozempic face' or 'Mounjaro face', a hollowed or more aged facial look, is a consequence of weight loss, including loss of facial fat, rather than the medicine acting on the skin 3. Any significant weight loss can do this. It is part of the wider weight-loss picture to discuss with your prescriber, not a separate skin problem 3.Can Mounjaro cause an allergic reaction?
Yes, rarely. The SmPC lists hypersensitivity reactions, and the pen's benzyl alcohol can rarely cause allergic reactions 12. The NHS lists a serious allergic reaction (anaphylaxis), with a swollen throat or tongue, a raised itchy rash or difficulty breathing, among the rare serious side effects, which needs emergency attention 3.What should I do about a rash from Mounjaro?
For a mild rash or itchy skin, speak to a pharmacist or doctor about managing it, and keep rotating your injection site 13. Treat a widespread, severe or blistering rash, or any rash with swelling or breathing difficulty, as urgent and call 111 3. You can report skin reactions through the MHRA Yellow Card scheme 1.Does Mounjaro cause hair loss?
It can. In the weight management trials, hair loss was reported in 4.9 percent of people on tirzepatide versus 1 percent on placebo, was mostly mild, and most people recovered while still on treatment 1. Like facial changes, it is partly linked to weight loss itself, which can trigger temporary shedding 1. Persistent or severe hair loss is worth raising with a clinician 3.Your next step
On the skin, Mounjaro's recognised effects are mainly injection site reactions and occasional hypersensitivity reactions such as rash, mostly mild, plus reported hair loss that usually recovers. 'Ozempic face' and facial changes are a result of weight loss rather than the drug acting on the skin, and belong to the wider weight-loss conversation.
Rotate your injection site to reduce reactions, speak to a pharmacist or doctor about persistent or bothersome skin effects, and treat a serious allergic reaction or severe spreading rash as an emergency. Report skin reactions through the Yellow Card scheme, and raise facial changes with your prescriber as part of your overall weight-loss plan.
Disclaimer
This guide is for general information only and does not constitute medical advice, diagnosis or treatment. The information here describes general clinical context based on UK regulatory sources cited above; it is not a recommendation for any specific medicine or treatment, which can only be made by a prescriber following individual assessment.
If you are considering treatment, speak to your GP or pharmacist, or arrange a consultation with a Cloud Pharmacy clinician. Prescription-only medicines are issued only after clinical assessment and where appropriate.
If you experience side effects from any medicine, you can report them through the Yellow Card scheme at yellowcard.mhra.gov.uk.
